Pharmagen Company Insiders
Break down of Pharmagen's management performance can provide insight into the company performance.
| Mackie Barch Chairman Founder and Vice Chairman |
Pharmagen | Build AI portfolio with Pharmagen Stock |
Pharmagen Management Team Effectiveness
The company has return on total asset (ROA) of (0.5891) % which means that it has lost $0.5891 on every $100 spent on assets. This is way below average. Pharmagen's management efficiency ratios could be used to measure how well Pharmagen manages its routine affairs as well as how well it operates its assets and liabilities.Pharmagen Workforce Comparison
Pharmagen is regarded second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 198. Pharmagen retains roughly 24.0 in number of employees claiming about 12% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31. Pharmagen Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharmagen Price Series Summation is a cross summation of Pharmagen price series and its benchmark/peer.
Pharmagen Stakeholder
| Mackie Barch | Founder and Vice Chairman | Profile |
About Pharmagen Management Performance
The success or failure of an entity such as Pharmagen often depends on how effective the management is. Pharmagen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharmagen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharmagen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. PHARMAGEN INC operates under Medical Distribution classification in the United States and is traded on PNK Exchange. It employs 24 people.
Please note, the imprecision that can be found in Pharmagen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pharmagen. Check Pharmagen's Beneish M Score to see the likelihood of Pharmagen's management manipulating its earnings.
Pharmagen Workforce Analysis
Traditionally, organizations such as Pharmagen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharmagen within its industry.Pharmagen Manpower Efficiency
Return on Pharmagen Manpower
| Revenue Per Employee | 200.5K | |
| Net Loss Per Employee | 250K |
Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.